What laboratory tests should be ordered for a patient who is taking iron?

Laboratory Monitoring for Patients Taking Iron

For patients taking iron supplementation, check a complete blood count (CBC) with hemoglobin, serum ferritin, and transferrin saturation (TSAT) at 4-8 weeks after starting treatment or after the last dose. 1

Core Laboratory Tests

The essential labs to monitor iron therapy response include:

• CBC with hemoglobin: Should increase by 1-2 g/dL within 4-8 weeks of therapy 1
• Serum ferritin: Target ≥50 ng/mL in the absence of inflammation 1
• Transferrin saturation (TSAT): Calculated by dividing serum iron by total iron binding capacity (TIBC); target >20% 1

Critical Timing Considerations

Do not check iron parameters within 4 weeks of iron administration, especially after total dose infusions, as circulating iron interferes with assays and produces falsely elevated results 1. Hemoglobin should begin rising within 1-2 weeks, but wait the full 4-8 weeks for complete assessment 1.

Interpreting Results in Different Clinical Contexts

Without Inflammation

• Ferritin and TSAT are the best performing tests 1
• TSAT <20% has high sensitivity for diagnosing absolute or functional iron deficiency 1
• Ferritin <100 ng/mL has lower sensitivity (35-48%) but remains useful 1

With Inflammation or Chronic Disease

Ferritin becomes unreliable as an acute phase reactant. In these situations:

• TSAT remains reliable: <20% indicates iron deficiency even when ferritin is elevated 1
• Consider soluble transferrin receptor (sTfR): More sensitive in inflammatory conditions, elevated in iron deficiency and unaffected by inflammation 1
• Reticulocyte hemoglobin content (CHr) or equivalent (RET-He): Direct assessment of functional iron availability; >10% hypochromic cells indicates iron-deficient erythropoiesis (normal <2.5%) 1

Frequency of Monitoring

Monitoring frequency depends on the underlying cause:

• Single correctable cause (e.g., resolved bleeding): One follow-up at 4-8 weeks may suffice 1
• Ongoing losses (heavy menstrual bleeding, GI bleeding, inflammatory bowel disease): More frequent monitoring required 1
• Malabsorption conditions (bariatric surgery, celiac disease, autoimmune gastritis): Regular monitoring needed due to impaired absorption 1

Common Pitfalls to Avoid

1. Testing too early: Checking labs before 4 weeks yields spurious results from circulating iron 1
2. Relying solely on CBC: Normal hemoglobin and hematocrit don't exclude iron deficiency; individuals can have normal RBC indices but depleted iron stores 2
3. Ignoring discordant results: Elevated ferritin with low TSAT indicates functional iron deficiency in inflammatory states—treat based on TSAT 1
4. Missing functional iron deficiency: Patients may have adequate stores but insufficient iron delivery to bone marrow, particularly with erythropoietin therapy 3, 4

Additional Considerations

For patients with inadequate response to iron therapy, evaluate for:

• Ongoing blood loss
• Malabsorption
• Incorrect diagnosis
• Need for alternative iron formulation (IV vs oral) 1

In specialized populations (CKD, heart failure, pregnancy), different ferritin thresholds may apply, with targets sometimes reaching 100-200 ng/mL or higher 5, 6.